Oilfield services firm Core Laboratories' Q4 revenue rises

Core Laboratories

04/02/2026 22:23

Overview

Oilfield services firm's Q4 revenue rose 7% yr/yr

Company repurchased 363,207 shares for $5.7 mln

Outlook

Core Laboratories projects Q1 2026 revenue between $124 mln and $130 mln

Company expects Q1 2026 EPS to be $0.11 to $0.15

Result Drivers

INTERNATIONAL DEMAND - Strong international demand for proprietary technologies drove revenue growth, with significant contributions from unconventional reservoir rock testing in the Middle East

REGIONAL STUDY SALES - Increased sales of regional studies in Africa and Brazil contributed to revenue, reflecting renewed exploration interest

OFFSHORE PROJECT - Successful completion of an offshore project using PAC™ technology reduced costs and execution time, contributing positively to results

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q4 Revenue
Beat
$138.30 mln
$131.10 mln (2 Analysts)
Q4 EPS
$0.15


Analyst Coverage

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", 1 "hold" and 1 "sell" or "strong sell"

The average consensus recommendation for the business support services peer group is "buy."

Wall Street's median 12-month price target for Core Laboratories Inc is $14.00, about 28.6% below its February 4 closing price of $19.61

The stock recently traded at 23 times the next 12-month earnings vs. a P/E of 19 three months ago

Press Release: ID:nPn9XqwM2a

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)